A wide range of diseases have been treated using low-molecular-weight heparins (LMWHs). the drug of choice for anticoagulation. Owing to their better pharmacokinetic features compared to those of unfractionated heparin (uFH). several systems incorporating LMWHs have been investigated to deliver and improve their therapeutic outcomes. https://www.roneverhart.com/Stardust-XLF/